Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03564054 · ClinicalTrials.gov registry record · NA
Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03564054: Clinical Trial NA study, sponsored by University of Florida.
NCT03564054 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03564054, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the efficacy of photodynamic therapy (PDT) in relieving airway obstruction in subjects with lung cancer compared to treatment with argon plasma coagulation (APC).
Primary Outcome
Measure the time until treatment failure. Treatment failure is defined in this study as the occurrence of any of the following: failure to improve airway patency, airway-re-obstruction, need for additional airway intervention, and/or worsening symptoms at 90 days after the last PDT or APC treatment .
Interventions
- PROCEDURE Photodynamic Therapy
- PROCEDURE Argon Plasma Coagulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2018-10-11 |
| Est. Completion | 2019-09-30 |
| Phase | NA |
Why NCT03564054 stopped before completion
NCT03564054 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Photodynamic Therapy is the first listed.
NCT03564054 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03564054 about?
NCT03564054 is a clinical study titled "Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction". The purpose of the study is to assess the efficacy of photodynamic therapy (PDT) in relieving airway obstruction in subjects with lung cancer compared to treatment with argon plasma coagulation (APC).
What is the current status of trial NCT03564054?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2018-10-11. Estimated completion is 2019-09-30.
What interventions are being tested in trial NCT03564054?
The interventions under investigation include: Photodynamic Therapy (PROCEDURE), Argon Plasma Coagulation (PROCEDURE).
Who is sponsoring clinical trial NCT03564054?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03564054's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI